The cardiovascular devices market includes a wide range of medical equipment used to diagnose, monitor, and treat heart and vascular conditions. Key products comprise stents, pacemakers, defibrillators, cardiac monitors, catheters, and heart valves—used in both surgical and minimally invasive procedures. Market growth is driven by rising incidence of cardiovascular diseases, expanding geriatric populations, and advances in device technologies—such as implantable miniaturized systems and remote monitoring platforms. Innovation in materials (like drug-eluting coatings), robotics-assisted interventions, and wireless connectivity are enhancing outcomes. As healthcare access improves globally and adoption of preventive cardiology increases, the market for cardiovascular devices is expected to expand steadily.
According to Fortune Business Insights, the global cardiovascular devices market was valued at USD 61.39 billion in 2023. The market is projected to grow from USD 65.53 billion in 2024 to USD 117.68 billion by 2032, exhibiting a CAGR of 7.6% during the forecast period. In 2023, North America dominated the cardiovascular devices market with a market share of 52.24%.
In November 2023, Cardio Diagnostics Holdings partnered with Vizient to develop AI‑powered cardiovascular tests. This collaboration reflects the industry's increasing integration of cutting‑edge diagnostic tools to enhance accuracy and patient outcomes.